StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)

Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –

Quest Diagnostics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Quest Diagnostics's revenue for the twelve months ending Sep 30, 2026 was $11.84B, up 9.1% year over year. For fiscal 2025 it was $11.04B, up 11.8% from the year before. Over ten years it grew 3.9% a year on average. The highest annual figure on record is $11.04B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.04B+11.8%
FY2024Dec 31, 2024$9.87B+6.7%
FY2023Dec 31, 2023$9.25B-6.4%
FY2022Dec 31, 2022$9.88B-8.4%
FY2021Dec 31, 2021$10.79B+14.3%
FY2020Dec 31, 2020$9.44B+22.1%
FY2019Dec 31, 2019$7.73B+2.6%
FY2018Dec 31, 2018$7.53B+1.7%
FY2017Dec 31, 2017$7.40B+2.6%
FY2016Dec 31, 2016$7.21B-3.7%
FY2015Dec 31, 2015$7.49B+0.8%
FY2014Dec 31, 2014$7.44B+4.0%
FY2013Dec 31, 2013$7.15B-3.2%
FY2012Dec 31, 2012$7.38B-0.1%
FY2011Dec 31, 2011$7.39B+1.8%
FY2010Dec 31, 2010$7.26B-2.6%
FY2009Dec 31, 2009$7.46B+2.8%
FY2008Dec 31, 2008$7.25B+8.1%
FY2007Dec 31, 2007$6.70B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.10B+10.0%
Q2 FY2026Jun 30, 2026$3.04B+10.2%
Q1 FY2026Mar 31, 2026$2.90B+9.2%
Q4 FY2025Dec 31, 2025$2.81B+7.1%
Q3 FY2025Sep 30, 2025$2.82B+13.2%
Q2 FY2025Jun 30, 2025$2.76B+15.2%
Q1 FY2025Mar 31, 2025$2.65B+12.1%
Q4 FY2024Dec 31, 2024$2.62B+14.6%
Q3 FY2024Sep 30, 2024$2.49B+8.4%
Q2 FY2024Jun 30, 2024$2.40B+2.5%
Q1 FY2024Mar 31, 2024$2.37B+1.5%
Q4 FY2023Dec 31, 2023$2.29B-1.9%
Q3 FY2023Sep 30, 2023$2.30B-7.7%
Q2 FY2023Jun 30, 2023$2.34B-4.7%
Q1 FY2023Mar 31, 2023$2.33B-10.7%
Q4 FY2022Dec 31, 2022$2.33B-15.0%
Q3 FY2022Sep 30, 2022$2.49B-10.4%
Q2 FY2022Jun 30, 2022$2.45B-3.8%
Q1 FY2022Mar 31, 2022$2.61B-4.0%
Q4 FY2021Dec 31, 2021$2.74B-8.6%
Q3 FY2021Sep 30, 2021$2.77B-0.4%
Q2 FY2021Jun 30, 2021$2.55B+39.6%
Q1 FY2021Mar 31, 2021$2.72B+49.3%
Q4 FY2020Dec 31, 2020$3.00B+55.9%
Q3 FY2020Sep 30, 2020$2.79B+42.4%
Q2 FY2020Jun 30, 2020$1.83B-6.5%
Q1 FY2020Mar 31, 2020$1.82B-3.6%
Q4 FY2019Dec 31, 2019$1.93B+4.7%
Q3 FY2019Sep 30, 2019$1.96B+3.5%
Q2 FY2019Jun 30, 2019$1.95B+1.8%
Q1 FY2019Mar 31, 2019$1.89B+0.4%
Q4 FY2018Dec 31, 2018$1.84B-1.4%
Q3 FY2018Sep 30, 2018$1.89B+1.8%
Q2 FY2018Jun 30, 2018$1.92B+3.0%
Q1 FY2018Mar 31, 2018$1.88B+3.7%
Q4 FY2017Dec 31, 2017$1.87B+0.2%
Q3 FY2017Sep 30, 2017$1.86B–
Q2 FY2017Jun 30, 2017$1.86B–
Q1 FY2017Mar 31, 2017$1.82B–
Q4 FY2016Dec 31, 2016$1.86B–

More Quest Diagnostics figures

See a number that looks wrong?